source
- Scancell to merge into Neuphoria and seek $89 million equity as AstraZeneca's breast cancer drug gains EU approvalScancell announced it will merge into Neuphoria Therapeutics, taking over Neuphoria's Nasdaq listing ($NEUP) and planning to change the ticker to SCLT. The combined entity aims to raise up to $89 m…
- Biotech hubs from Abu Dhabi to Brazil compete to become the next emerging economyFierce reporters attended the Biotechnology Innovation Organization conference in San Diego to gauge how biotech hubs worldwide are positioning themselves amid tariff concerns and China’s growing i…